Oglycosylation is a ubiquitous posttranslational modification present in secreted and membranebound proteins. Polypeptide Nacetylgalactosaminyltransferases (GALNTs) catalyze the initial step for Oglycosylation by transferring GalNAc to Thr or Ser residues (GalNAc alpha 1OSer/Thr) in the Golgi compartment. Structurally, the GALNTs consist of an Nterminal catalytic domain tethered by a short linker to a Cterminal ricinlike lectin domain containing three potential carbohydratebinding sites (1, 2). Twenty distinct GALNT isoforms have been detected in humans. These isoforms display both unique and overlapping substrate specificities (3, 4, 5) with no known universal consensus glycosylation sequence. Glycosylation of mucins results from the successive, often hierarchical, action of several specific GALNTs (6). GALNTL1 is active toward nonglycosylated peptides as well as some glycosylated peptides and is widely expressed in most tissues, especially high in heart, spinal cord and brain (7). Phylogenetically, GALNTL1 is closely related to GALNT2 and GALNT14 (8). The enzymatic activity of recombinant human GALNTL1 was determined using a phosphatasecoupled assay (9).
Source:Recombinant protein corresponding to Asp27-Thr558 from human GALNTL1, fused to 6-his tag at C-terminal, NS0-derived.
Molecular Weight:~55-61kD
Endotoxin:<1.0EU/1ug (LAL method)
Storage and Stability:May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
Size:20ug
Source Antigen:Recombinant
Grade:Purified
Purity:~90% (SDS-PAGE)
Form:Supplied as a liquid in Tris, NaCl. BSA free.